Satsuma Pharmaceuticals, Inc.
STSADelisted Jun 8, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001692830
Satsuma Pharmaceuticals, Inc. was delisted on Jun 8, 2023; its insiders filed their last Form 4 on Jun 12, 2023; 31 institutions reported holding it in 13F filings for Q1 2023, worth $12.7M in total; no superinvestor held it.
13F holders, Q3 2022
Institutional positions in Satsuma Pharmaceuticals, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 41
- +9 vs. Q2 2022
- Shares held
- 24.4M
- +1.68M (+7.4%) vs. Q2 2022
- Total value
- $146.7M
- +$52.5M (+55.7%) vs. Q2 2022
- New holders
- 14
- 10 more added
- Sold out
- 5
- 11 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting STSA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 31 | $12.7M |
| Q4 2022 | 33 | $17.8M |
| Q3 2022 | 41 | $146.7M |
| Q2 2022 | 32 | $94.2M |
| Q1 2022 | 36 | $87.7M |
| Q4 2021 | 35 | $103.6M |
| Q3 2021 | 45 | $108.3M |
| Q2 2021 | 60 | $167.4M |
| Q1 2021 | 61 | $136.3M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Satsuma Pharmaceuticals, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 27 | $0 | 0.00% | −17,567−99.8% | Reduced |
| BNP Paribas Arbitrage, SA | 59 | $354 | 0.00% | +59 | New |
| Wells Fargo & Company | 134 | $1.00K | 0.00% | +16+13.6% | Added |
| Federated Hermes, Inc. | 100 | $1.00K | 0.00% | +100 | New |
| Tower Research Capital LLC (TRC) | 110 | $1.00K | 0.00% | +110 | New |
| Advisor Group Holdings, Inc. | 1,000 | $6.00K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 6,585 | $40.0K | 0.00% | −488−6.9% | Reduced |
| Renaissance Technologies LLC | 10,000 | $60.0K | 0.00% | +10,000 | New |
| Marshall Wace, LLP | 10,123 | $61.0K | 0.00% | +10,123 | New |
| Virtu Financial LLC | 10,096 | $61.0K | 0.01% | +10,096 | New |
| Two Sigma Investments, LP | 10,529 | $63.0K | 0.00% | −3,140−23.0% | Reduced |
| Schonfeld Strategic Advisors LLC | 11,300 | $68.0K | 0.00% | −100−0.9% | Reduced |
| Boothbay Fund Management, LLC | 11,968 | $72.0K | 0.00% | −52,872−81.5% | Reduced |
| Susquehanna International Group, LLP | 12,050 | $72.0K | 0.00% | +12,050 | New |
| Bank of New York Mellon Corp | 16,262 | $98.0K | 0.00% | +16,262 | New |
| Bank of America Corp | 18,495 | $111.0K | 0.00% | +18,495 | New |
| Two Sigma Advisers, LP | 34,800 | $209.0K | 0.00% | −2,800−7.4% | Reduced |
| Northern Trust Corp | 42,269 | $254.0K | 0.00% | +4,334+11.4% | Added |
| State Street Corp | 62,236 | $373.0K | 0.00% | +19,200+44.6% | Added |
| Millennium Management LLC | 62,116 | $373.0K | 0.00% | +62,116 | New |
| Simplex Trading, LLC | 67,823 | $406.0K | 0.02% | +67,823 | New |
| Caption Management, LLC | 90,000 | $539.0K | 0.09% | +90,000 | New |
| Walleye Capital LLC | 93,672 | $562.0K | 0.01% | −57,756−38.1% | Reduced |
| Bridgeway Capital Management, LLC | 115,300 | $692.0K | 0.02% | −12,000−9.4% | Reduced |
| Ikarian Capital, LLC | 136,059 | $815.0K | 0.41% | −517,389−79.2% | Reduced |
| EAM Investors, LLC | 149,029 | $894.0K | 0.19% | +149,029 | New |
| BlackRock Inc. | 152,180 | $913.0K | 0.00% | +14,940+10.9% | Added |
| Nan Fung Group Holdings Ltd | 177,900 | $1.07M | 0.68% | +35,000+24.5% | Added |
| Geode Capital Management, LLC | 191,445 | $1.15M | 0.00% | +26,707+16.2% | Added |
| Barclays PLC | 218,902 | $1.31M | 0.00% | +16,424+8.1% | Added |
| Morgan Stanley | 223,816 | $1.34M | 0.00% | −22,876−9.3% | Reduced |
| Dimensional Fund Advisors LP | 276,266 | $1.66M | 0.00% | +39,731+16.8% | Added |
| Ameriprise Financial Inc | 796,865 | $4.78M | 0.00% | +39,380+5.2% | Added |
| Vanguard Group Inc | 909,390 | $5.46M | 0.00% | +269,026+42.0% | Added |
| Vivo Capital, LLC | 1,232,394 | $7.39M | 0.82% | 00.0% | Unchanged |
| Driehaus Capital Management LLC | 1,714,046 | $10.3M | 0.16% | +1,714,046 | New |
| TPG GP A, LLC | 1,885,939 | $11.3M | 0.19% | 00.0% | Unchanged |
| Samlyn Capital, LLC | 2,929,195 | $17.6M | 0.34% | −15,060−0.5% | Reduced |
| NEA Management Company, LLC | 3,142,958 | $18.9M | 0.94% | 00.0% | Unchanged |
| Commodore Capital LP | 3,711,286 | $22.3M | 3.58% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 5,914,252 | $35.5M | 0.76% | 00.0% | Unchanged |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −150,954−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −46,998−100.0% | Sold out |
| Norges Bank | 0 | $0 | 0.00% | −17,700−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −12,319−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −10,109−100.0% | Sold out |